AFCG vs REGN · rev $15.6M vs P/E 14, rev $4.29B
AFC Gamma Inc (AFCG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AFC Gamma Inc (AFCG) is a asset management company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AFCG revenue for 2026-06-30 was $15.6M. Net income was $16.8M. AFCG currently screens at market cap $77.2M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AFCG currently screens at market cap $77.2M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AFCG and REGN stock pages for the full models.
Not investment advice.